GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CROSSJECT (XPAR:ALCJ) » Definitions » Cash-to-Debt

CROSSJECT (XPAR:ALCJ) Cash-to-Debt : 0.12 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is CROSSJECT Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. CROSSJECT's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.12.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, CROSSJECT couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for CROSSJECT's Cash-to-Debt or its related term are showing as below:

XPAR:ALCJ' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.12   Med: 0.58   Max: No Debt
Current: 0.12

During the past 13 years, CROSSJECT's highest Cash to Debt Ratio was No Debt. The lowest was 0.12. And the median was 0.58.

XPAR:ALCJ's Cash-to-Debt is ranked worse than
90.45% of 859 companies
in the Medical Devices & Instruments industry
Industry Median: 1.83 vs XPAR:ALCJ: 0.12

CROSSJECT Cash-to-Debt Historical Data

The historical data trend for CROSSJECT's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

CROSSJECT Cash-to-Debt Chart

CROSSJECT Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.34 0.39 0.55 0.12

CROSSJECT Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.44 0.55 0.25 0.12

Competitive Comparison of CROSSJECT's Cash-to-Debt

For the Medical Instruments & Supplies subindustry, CROSSJECT's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CROSSJECT's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CROSSJECT's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where CROSSJECT's Cash-to-Debt falls into.



CROSSJECT Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

CROSSJECT's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

CROSSJECT's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CROSSJECT  (XPAR:ALCJ) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


CROSSJECT Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of CROSSJECT's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


CROSSJECT Business Description

Traded in Other Exchanges
Address
60L avenue du 14 Juillet, Chenôve, FRA, 21300
CROSSJECT manufactures and markets needle-free drug self-injection system.

CROSSJECT Headlines

No Headlines